Overall, the general practitioner is left with a number of risk factors, which implies that a customized approach is appropriate, and one might imagine a protocol based on initial level and BMI, similar to starting insulin on a diabetic or levothyroxine in a patient with hypothyroidism, but no prospective studies that indicate how this should effectively be done. The gene discussed is INS; the disease is hypothyroidism.